Knowledge and Attitude About HPV Vaccines

NCT ID: NCT01043341

Last Updated: 2010-01-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-10-31

Study Completion Date

2009-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study was to analyze the knowledge and attitude about HPV vaccines among Brazilian women after an educative intervention. The knowledge was measured on sexual behavior and HPV infection. The attitude was measured on acceptance of vaccines.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Two hundred Brazilian women were selected ranged 18 to 30 years old. They were randomized on two groups: 1) One hundred received a brief educative intervention about HPV infection and vaccines and answered a questionaire about sexual behavior, HPV infection and vaccines and 2)one hundred not received anything and answered the same questionaire.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Knowledge Attitude Behavior

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

behavioral

the women received a folder about HPV infection and vaccines and answered a questionaire about sexual behavior, HPV infection and vaccines.

Group Type ACTIVE_COMPARATOR

educative folder

Intervention Type BEHAVIORAL

folder about HPV infection and vaccines

no intervention

the women answered a questionaire about sexual behavior, HPV infection and vaccines

Group Type NO_INTERVENTION

educative folder

Intervention Type BEHAVIORAL

folder about HPV infection and vaccines

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

educative folder

folder about HPV infection and vaccines

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

HPV vaccines information

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* healthy women

Exclusion Criteria

* previous CIN or cervical cancer treatment
Minimum Eligible Age

18 Years

Maximum Eligible Age

30 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universidade Cidade de Sao Paulo

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Universidade Cidade de São Paulo

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sylvia MF Brenna, MD, PHD

Role: STUDY_DIRECTOR

Universidade Cidade de São Paulo

Kari J Sirjanen, MD, PhD

Role: STUDY_CHAIR

University of Turku

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Universidade Cidade de São Paulo

São Paulo, São Paulo, Brazil

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Brazil

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HPV vaccines

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Impact of Standing Orders Optimization
NCT05742386 ACTIVE_NOT_RECRUITING NA